After severe kidney injury in diabetes, GLP-1 drugs and SGLT2 inhibitors show divergent brain-health signals
A large retrospective cohort study finds that GLP-1 receptor agonists and SGLT2 inhibitors were linked to different, time-dependent neuropsychiatric outcomes ...
